Results 11 to 20 of about 239,955 (288)

Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association

open access: yesCirculation, 2022
The use of temporary mechanical circulatory support in cardiogenic shock has increased dramatically despite a lack of randomized controlled trials or evidence guiding clinical decision-making.
Bram J Geller   +12 more
semanticscholar   +1 more source

Single-Center Experience With Protocolized Treatment of Left Ventricular Assist Device Infections

open access: yesFrontiers in Medicine, 2022
PurposeBecause of the current lack of evidence-based antimicrobial treatment guidelines, Left Ventricular Assist Device (LVAD) infections are often treated according to local insights.
Nelianne J. Verkaik   +11 more
doaj   +1 more source

Use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock

open access: yesEuropean Journal of Heart Failure, 2023
Despite its high incidence and mortality risk, there is no evidence‐based treatment for non‐ischaemic cardiogenic shock (CS). The aim of this study was to evaluate the use of mechanical circulatory support (MCS) for non‐ischaemic CS treatment.
B. Schrage   +42 more
semanticscholar   +1 more source

Temporary Mechanical Circulatory Support in Patients with Cardiogenic Shock: Clinical Characteristics and Outcomes

open access: yesJournal of Clinical Medicine, 2023
Patients with cardiogenic shock may require stabilization with temporary mechanical circulatory support (tMCS) to assess candidacy for definitive therapy, including heart transplantation (HTx) or durable MCS, and/or maintain stability while on the HTx ...
Michael Abiragi   +8 more
semanticscholar   +1 more source

Prediction, prevention, and management of right ventricular failure after left ventricular assist device implantation: A comprehensive review

open access: yesFrontiers in Cardiovascular Medicine, 2022
Left ventricular assist devices (LVADs) are increasingly common across the heart failure population. Right ventricular failure (RVF) is a feared complication that can occur in the early post-operative phase or during the outpatient follow-up.
Eduard Rodenas-Alesina   +10 more
doaj   +1 more source

Temporary mechanical circulatory support devices: practical considerations for all stakeholders

open access: yesNature Reviews Cardiology, 2022
Originally intended for life-saving salvage therapy, the use of temporary mechanical circulatory support (MCS) devices has become increasingly widespread.
B. Salter   +8 more
semanticscholar   +1 more source

Temporary Mechanical Circulatory Support in Cardiogenic Shock Patients after Cardiac Procedures: Selection Algorithm and Weaning Strategies

open access: yesLife, 2023
Mechanical circulatory support has proven effective in managing postcardiotomy cardiogenic shock by stabilizing patients’ hemodynamics and ensuring adequate organ perfusion.
G. Nersesian   +18 more
semanticscholar   +1 more source

Venoarterial extracorporeal membrane oxygenation as mechanical circulatory support in adult septic shock: a systematic review and meta-analysis with individual participant data meta-regression analysis

open access: yesCritical Care, 2021
While recommended by international societal guidelines in the paediatric population, the use of venoarterial extracorporeal membrane oxygenation (VA ECMO) as mechanical circulatory support for refractory septic shock in adults is controversial.
R. Ling   +7 more
semanticscholar   +1 more source

Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock

open access: yesESC Heart Failure, 2021
The management of cardiogenic shock remains a clinical challenge even in well‐developed healthcare systems, best illustrated by its high mortality despite numerous innovative proposals for management. The aim of this study was to describe temporal trends
B. Schrage   +12 more
semanticscholar   +1 more source

A Comprehensive Review of Mechanical Circulatory Support Devices.

open access: yesHeart International, 2022
Treatment strategies to combat cardiogenic shock (CS) have remained stagnant over the past decade. Mortality rates among patients who suffer CS after acute myocardial infarction (AMI) remain high at 50%.
V. Atti   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy